BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barner-Rasmussen N, Pukkala E, Hadkhale K, Färkkilä M. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland. United European Gastroenterol J 2021. [PMID: 34533900 DOI: 10.1002/ueg2.12154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen L, Fan Z, Sun X, Qiu W, Mu W, Chai K, Cao Y, Wang G, Lv G. Examination on the risk factors of cholangiocarcinoma: A Mendelian randomization study. Front Pharmacol 2022;13:900424. [DOI: 10.3389/fphar.2022.900424] [Reference Citation Analysis]
2 Beheshti-Maal A, Tamimi A, Iravani S, Memarnejadian A, Sorouri M, Aghdaei HA, Zali MR, Hossein Khannazer N, Vosough M. PSC associated inflammatory bowel disease: A distinct entity. Expert Rev Gastroenterol Hepatol 2022. [PMID: 35078376 DOI: 10.1080/17474124.2022.2031979] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Izquierdo-Sanchez L, Banales JM, Rodrigues PM. A look back at cholangiocarcinoma in Finland. United European Gastroenterol J 2021. [PMID: 34581503 DOI: 10.1002/ueg2.12157] [Reference Citation Analysis]